Latest News

Keep up to date with the latest news from our team at the Kolling Institute of Medical Research. By subscribing to our newsletter, you’ll discover more about our dedicated teams and their latest findings. You’ll have access to information about upcoming events and you’ll hear about opportunities to support our research.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Age and sex influence the adverse effects of multiple medications

Age and sex influence the adverse effects of multiple medications

There are calls for a carefully-considered, tailored approach to the prescription of multiple medicines with new research finding a person’s age and sex influence the impact of multiple medications. More than half of older Australians take five or more regular medications, with the higher number of medications directly linked to a higher chance of adverse reactions, like falls, confusion..... Read more

Category: Neuroscience and Pain Research, New Treatment

Technology to bring relief to those with low back pain

Technology to bring relief to those with low back pain

With many of us looking to adopt a healthier lifestyle, researchers say a new approach may not only deliver benefits for your heart and waistline but may reduce low back pain as well. The condition affects one in six Australians or four million people and is the leading cause of adult musculoskeletal pain worldwide. Researchers from the University of Sydney and the Kolling Institute have..... Read more

Category: Musculoskeletal Research, Research Excellence

High tech project offers hope for Parkinson’s treatment

High tech project offers hope for Parkinson’s treatment

Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson's disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific progress..... Read more

Category: Funding support

First large-scale trial of stem cell therapy for knee osteoarthritis launched

First large-scale trial of stem cell therapy for knee osteoarthritis launched

Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor Hunter, the Florance and Cope ..... Read more

Category: Musculoskeletal Research, New Treatment

First Australian imaging technology to deliver research windfall

First Australian imaging technology to deliver research windfall

An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities. Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with l..... Read more

Category: World-leading technology

A simple mix of treatments holds the key to better hand function

A simple mix of treatments holds the key to better hand function

The base of our thumb may just be a small part of our hand, but osteoarthritis in that area can have a significant impact, making the simplest tasks difficult. The condition especially affects post-menopausal women, with figures indicating up to a third of women over 70 have this type of osteoarthritis. Increasing numbers of people are experiencing the condition, and yet current treatme..... Read more

Category: Musculoskeletal Research, New Treatment

Researchers drive global call to action to tackle world’s leading cause of death

Researchers drive global call to action to tackle world’s leading cause of death

A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and mid..... Read more

Category: Cardiovascular and Renal Research

Research identifies long-term health impacts of minor crashes

Research identifies long-term health impacts of minor crashes

Treatment of whiplash injuries may be modified following research which has found even minor motor vehicle accidents can cause a long-term spinal cord injury. Researchers from the Kolling Institute along with scientists from Northwestern, Stanford and the University of Oklahoma conducted the longitudinal study involving participants who had been involved in a relatively simple rear-end m..... Read more

Category: Musculoskeletal Research

Research highlights the dangers of early births

Research highlights the dangers of early births

Doctors and researchers are increasingly concerned at the steady rise in premature twin births in New South Wales. Professor Jonathan Morris and his team from the Kolling’s Women and Babies Research group analysed over 14,000 twin pregnancies from 2003-2014, finding 49 per cent of twins were born premature before 37 weeks, and 69 per cent of all births were planned either by pre-labour c..... Read more

Category: Research Excellence

Our researchers secure highly competitive national funding

Our researchers secure highly competitive national funding

Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC) More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease. The world-first pro..... Read more

Category: Cardiovascular and Renal Research